OncLive® Presents Its Latest State of the Science Summit™ on Genitourinary Cancers

CRANBURY, N.J.--(BUSINESS WIRE)-- OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on genitourinary cancers. The summit will take place on Thursday, Nov. 29, from 5-9 p.m. at the Marriott Memphis East in Tennessee. Chairs of the summit include Daniel J. George, M.D., medical oncologist, Duke Hospital Cancer Institute, and Bradley G. Somer, M.D., associate professor, department of hematology and medical oncology, University of Tennessee Health Science Center, and medical oncologist; senior partner, executive cancer council; and head of strategic expansion/development, West Cancer Center.

This interactive and educational summit will discuss the treatment of patients with genitourinary cancers. Expert presenters will delve into the role of cytoreductive nephrectomy in metastatic renal cell carcinoma (RCC), the role of adjuvant (TKI) in mRCC, the current and future roles of immunotherapy and TKIs in mRCC, management of treatment-related toxicities in mRCC, androgen therapy deprivation-associated cardiac complications, treatment of non-metastatic castration-resistant prostate cancer, metastatic castration-naïve prostate cancer and management of metastatic prostate cancer. The presenters will also engage in a peer exchange discussion and address audience questions.

Presenters for the summit include:

• Paul R. Eber, M.D., urologist, The Conrad Pearson Clinic.
• Jay H. Fowke, Ph.D., MPH, chief, division of epidemiology, professor, department of preventive medicine, University of Tennessee Health Science Center.
• Holger L. Gieschen, M.D., assistant professor, department of radiology, The University of Tennessee Health Science Center, and radiation oncologist, West Cancer Center.
• Heather Greene, MSN, FNP, AOCNP, oncology nurse practitioner, West Cancer Center.
• Harsha Ranganath, M.D., fellow, University of Tennessee Health Science Center.
• Walter Rayford, M.D., Ph.D., MBA, urologic oncologist, The Urology Group.
• Susan F. Slovin, M.D., Ph.D., associate chair, academic administration, department of medicine, Memorial Sloan Kettering Cancer Center.
• Daniel Vaena, M.D., medical oncologist and hematologist, West Cancer Center.

State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.

Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit https://www.onclive.com/meetings/soss or contact Kayla Collins at kcollins@curetoday.com.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181120005695/en/